Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ChiRex to supply Glaxo Wellcome with intermediates from former Glaxo plant in Scotland.

Executive Summary

CHIREX TO SUPPLY RANITIDINE INTERMEDIATES TO GLAXO WELLCOME from a former Glaxo plant in Annan, Scotland, under a letter of intent announced July 7. The Annan facility produces pharmaceutical intermediates used in several Glaxo Wellcome products, including Tritec (ranitidine bismuth citrate, called Pylorid in Europe) and Zantac (ranitidine). Under the agreement, ChiRex will purchase the Annan plant but will continue to supply Glaxo Wellcome with the intermediates for at least five years.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS030531

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel